Search Results

CNNC Hosts the 6th Radiopharmaceutical and Radionuclide Production Worker Vocational Skills Competition, Leveraging Shared Laboratories to Deepen Skilled Talent Cultivation

The 2026 6th CNNC Radiopharmaceutical and Radionuclide Production Worker Vocational Skills Competition, themed "Forging Craftsmanship with Nuclear Power, Winning the Future with Skills," was successfully held from October 20 to 24 at the Nuclear and Radiation Safety Center of the Ministry of Ecology and Environment. The competition was hosted by CNNC and organized by China Isotope & Radiation Corporation, and is a key practical measure for CNNC and the Nuclear and Radiation Safety Center to deepen strategic coordination and advance the construction of shared laboratories. The two sides closely focused on research directions including radiation environmental monitoring, nuclide analysis, and precise sample testing, promoting the co-construction and sharing of instruments and equipment, reference materials, methodology systems, and data platforms. A total of 16 units and 3...

2026-10-25

The 18th National Symposium on Radiopharmaceuticals and Labeled Compounds Held in Chongqing, Focusing on Alpha Nuclide Targeting and Theranostics

The 18th National Symposium on Radiopharmaceuticals and Labeled Compounds was held on October 10-11 at the Chongqing Science Hall. The conference was co-hosted by the China Isotope & Radiation Corporation Research Institute and the IAEA Collaborating Centre for Radiopharmaceuticals and Radioactive Sources, co-organized by the Nuclear Medicine Branch of the Chinese Medical Association, the Isotope Branch of the Chinese Nuclear Society, the Radiopharmaceuticals Branch of the Chinese Nuclear Society, and the Nuclear Chemistry and Radiochemistry Branch of the Chinese Nuclear Society, and undertaken by China Isotope & Radiation Corporation and the Chongqing Nuclear Society. More than 400 experts, scholars, clinicians and...

2026-10-12

CNNC Headway's Self-Developed 50mg Urea [¹³C] Powder Sachet Kit Approved, Establishing an Independent "Dual Dosage Form, Dual Specification" Landscape for Carbon-13 Breath Diagnosis

On October 8, 2026, the 50mg urea [¹³C] powder sachet breath test kit independently developed by Shenzhen CNNC Headway Biotechnology Co., Ltd. (CNNC Headway), a subsidiary of China Isotope & Radiation Corporation under CNNC, officially obtained the drug registration certificate issued by the National Medical Products Administration. This product is not only the first generic drug of the same variety approved for marketing in China in the 9 years since the implementation of the new drug review and approval regulations in 2017, but also another key achievement of CNNC Headway following the 75mg urea [¹³C] breath test kit becoming the first to pass the generic drug consistency evaluation, marking that China has officially formed a capsule + powder dual dosage form and 75mg + 50mg dual specification independent supply matrix in the field of Helicobacter pylori (Hp) breath testing...

2026-10-11

China Isotope & Radiation Plans to Invest RMB 400 Million in Zhejiang Nuclear Technology Application Industry Fund

China Isotope & Radiation Corporation announced on August 28 that its board of directors has approved entering into a partnership agreement with CNNC, CNNC Capital, CNNC Fund, National Industry Investment Fund, Zhejiang Venture Capital Guidance Fund, Jiaxing Changchuang Industrial Investment, and Haiyan County State-owned Capital Investment to jointly establish CNNC (Zhejiang) Nuclear Technology Application Industry Investment Fund Partnership (Limited Partnership). According to the announcement, the fund will be registered in Jiaxing City, Zhejiang Province, with partners intending to subscribe to a total capital contribution of RMB 3 billion. Among them, China Isotope & Radiation plans to contribute RMB 400 million from internal resources, accounting for 13.33% of the fund's total subscribed capital; CNNC Fund, as the general partner, plans to contribute RMB 30 million, accounting for 1%; the National...

2026-08-29

China Isotope & Radiation's National Headquarters for Irradiation Application Industry Settles in Guangzhou

On August 11, the national headquarters of China Isotope & Radiation's irradiation application industry — CNNC Irradiation (Guangdong) Technology Co., Ltd. (hereinafter referred to as "CNNC Irradiation") — officially settled in Tianhe District, Guangzhou, and entered the Pearl River New City. This marks an important milestone in the development of China Isotope & Radiation's irradiation application industry. The relocation of the national headquarters for irradiation application to Guangzhou is a key step for China Isotope & Radiation in implementing the central-local cooperation deployment between CNNC and Guangdong Province, and in strategically positioning for the "15th Five-Year Plan." As the nuclear technology application industry platform of CNNC, China Isotope & Radiation possesses a complete industrial chain and core technological advantages in the irradiation application field. It is a leading domestic provider of irradiation facility design, manufacturing, installation, and operation & maintenance services, and has accumulated extensive industrialization experience in high-end medical device sterilization, green irradiation processing of food and traditional Chinese medicinal materials, and material modification.

2026-08-14

China Isotope & Radiation Corporation (CIRC) Conducts Cooperation Exchange with Guangzhou Tianhe District

On July 29, a delegation led by Tan Minghe, Secretary of the Guangzhou Tianhe District Party Committee, visited China Isotope & Radiation Corporation (CIRC) and held a meeting with Xiao Yafei, Secretary of the CIRC Party Committee and Chairman. The two sides conducted in-depth discussions on the establishment of CIRC's isotope and irradiation subsidiaries in Guangzhou's Tianhe District. Tan Minghe introduced the economic and social development of Tianhe District. He stated that as the central urban area and the top economic district of Guangzhou, Tianhe has ranked first in Guangzhou and among the top in the country for several consecutive years. Tianhe District has clearly included life and health as a key development track in modern urban industry, with nuclear medicine as a key focus area, which is highly aligned with isotope-related industries. Tianhe District will fully support the relocation of CIRC's isotope and irradiation subsidiaries to Guangzhou, providing high-quality business environment for their establishment and development. Yuan Xiaoyi, Deputy District Mayor of Tianhe, provided a detailed introduction on the development of the medical industry in Tianhe and the high compatibility of future industries such as nuclides and nuclear drugs with Tianhe's resources.

2026-07-31

International Students of the "Chinese Government Atomic Energy Scholarship" Program Visit China Isotope & Radiation Corporation

On July 22 and July 29, over 50 international students from more than 10 countries, including Egypt, Pakistan, Ethiopia, Ghana, the Philippines, Cambodia, Mongolia, Bangladesh, Namibia, Nigeria, El Salvador, Sudan, Yemen, and Russia, who are part of the Chinese Government Atomic Energy Scholarship program, visited China Isotope & Radiation Corporation (CIRC). They experienced firsthand the vibrant vitality of China's nuclear technology application industry, enhancing their understanding and recognition of China's nuclear industry through tours and exchanges. First Stop: Atomic High-Tech Jinhui Radiation - When Nuclear Technology Enters Daily Life. The students visited Atomic High-Tech Jinhui Radiation to learn about the extensive applications of irradiation technology in medical sterilization, food preservation, aerospace testing, and other fields, and observed relevant process flows. A student from Pakistan exclaimed, "I never imagined irradiation technology had penetrated so deeply into various fields. This has given me a completely new understanding of the breadth of China's nuclear technology applications." The students engaged in lively interactions with technical staff on topics such as the safety and application prospects of irradiation technology.

2026-07-30

CNNC-CNI assists in the launch of the high-quality nuclear medicine diagnosis and treatment project at Mianyang Central Hospital.

A high-quality development project for nuclear medicine diagnosis and treatment was recently launched at Mianyang Central Hospital. An expert delegation from the Chinese Society of Nuclear Medicine (CSNM), accompanied by representatives from China Isotope

2026-07-27